 Connection
Anip Bansal to Gout Suppressants
This is a "connection" page, showing publications Anip Bansal has written about Gout Suppressants.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.244 |
|
|
|
-
Shenoy T, Sanchez-Almanzar D, Dias JA, Hayden R, Shashaty MG, Aklilu AM, Patell R, Anand S, Renaghan A, Bassil C, Neyra JA, Bansal A, Shah CV, Gupta S, Sise ME, Seethapathy R, Chase S, Thompson C, Radhakrishnan R, Verma E, Ni J, Hoge ST, Lypka V, Ali R, Monson AE, Kaunfer S, Angus E, Griffiths S, Walling C, Al Haddad N, Brotman CH, Miano T, Shirali AC, Turco DJ, Alleyne SA, Shelton K, Shaefi S, Garcia D, Nasim A, Jan N, Nguyen PH, Ziolkowski S, Subramanian N, Subramanian V, Debnath N, Faldu CT, Wickramasinghe K, Donahue BP, Shah A, Shostak J, Jayakumar V, Nadayil J, Baz R, Takeuchi T, Renzi S, Rehman AU, Nombera-Aznaran N, Charkviani M, Kotzin M, Kaiser J, Edwards M, Mathavan A, Mathavan A, Obimdike F, Shah N, LaCasce AS, Armand P, Leaf DE. Early treatment with rasburicase and risk of kidney replacement therapy and death in adults with tumour lysis syndrome: emulated target trial. BMJ. 2026 Jul 23; 394:e100040.
Score: 0.244
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|